Opsens To Present at the LD Micro Invitational

QUEBEC CITY, QC / ACCESSWIRE / May 22, 2019 / Opsens Inc. (“Opsens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a company focusing mainly on physiological measurements such as Fractional Flow Reserve (“FFR”) and Diastolic Pressure Ratio (“dPR”) in interventional cardiology, will present at the LD Micro 9th Invitational investor conference on Tuesday, June 4, 2019 at 8:40 am PST. Louis Laflamme, Opsens’ President and Chief Executive Officer, will give the presentation and host meetings with investors on both days the event will be held.

The event will take place at the Luxe Sunset Hotel in Bel Air, California on June 4th and 5th.

LD Micro is an independent resource in the microcap space. To register and attend the event, please visit https://www.ldmicro.com/events.

Investors wishing to schedule a meeting with Louis Laflamme should contact Marie-Claude Poitras at marie-claude.poitras@opsens.com.

View Opsens’ profile on LD Micro: https://www.ldmicro.com/profile/OPS.TO.

News Compliments of ACCESSWIRE

About Opsens Inc. (www.opsens.com or www.opsensmedical.com)

Opsens focuses mainly on physiological measurements such as FFR and dPR in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 60,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.

Opsens is also involved in industrial activities in developing, manufacturing and installing innovative fibre optic sensing solutions for critical applications.

Contact:

Louis Laflamme, CPA, CA, Chief Executive Officer, 418.781.0333
Robin Villeneuve, CPA, CA Chief Financial Officer, 418.781.0333

SOURCE: Opsens Inc.

View source version on accesswire.com:
https://www.accesswire.com/546180/Opsens-To-Present-at-the-LD-Micro-Invitational

user

Recent Posts

Therma Bright Q2, 2024 Market Update On Business

Medical Device Developer & Investor Taps 4 Markets With Growth Projections of USD $39.1B by…

43 mins ago

Danish start-up Kvantify secures EUR 10 million seed round to unlock quantum computing potential, starting with life sciences

The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…

2 hours ago

High-Growth Industries with 25%-30% CAGR Growth Over the Next Five Years

BCC Research Identifies Key Sectors with Substantial Growth Potential, Forecasting Significant Market Expansion Through 2029.…

2 hours ago

Bioz Brings Cutting-Edge AI Citation Widgets to Precision X-Ray, Inc.’s Product Pages

PALO ALTO, CA / ACCESSWIRE / July 3, 2024 / Bioz, Inc., a pioneering AI…

2 hours ago

iZafe Group Receives Confirmed Order of 500 Dosell Units from Ti Medi

STOCKHOLM, SWEDEN / ACCESSWIRE / July 3, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB…

2 hours ago

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza…

5 hours ago